معرفی
Ken Cornell is a Professor in the Department of Chemistry and Biochemistry at Boise State University. His research focuses on enzymology, antibiotic development targeting microbial salvage pathways, and plasma-based medical devices for wound treatment and industrial surface decontamination. He collaborates with Engineering faculty on plasma array technologies and develops antimicrobial materials for biomedical applications. Cornell holds patents for plasma-based antimicrobial devices and silver compositions.
Education
- Ph.D. in Biochemistry, Oregon Health & Sciences University (1997)
- M.S. in Microbiology, Wichita State University (1985)
- B.S. in Microbiology, Oregon State University (1983)
- Postdoctoral work in Biochemistry/Immunology at Portland VA Medical Center (1997-1998)
His research interests include:
- Novel antibiotics targeting bacterial/parasite methionine salvage
- Plasma devices for wound biofilm inactivation
- Antimicrobial polymer coatings
- Cancer drug efficacy testing via MALDI imaging
Grants
- USDA/NIFA: Food processing biofilm removal (2020-2023)
- NIH: Lyme disease antibiotic development (2017-2022)
- IDoBRE: Bioinformatics infrastructure support (2019-2022)
Teaching includes graduate-level biochemistry and directed research courses. His lab emphasizes long-term student involvement (minimum 1 year) for meaningful research experiences in antimicrobial development and plasma technology applications.
